The burgeoning optimism surrounding classic psychedelics as a transformative treatment for depression is beginning to face a crucial reality check.…
Read More
What if psilocybin works about as well for depression as an SSRI?
The burgeoning optimism surrounding classic psychedelics as revolutionary treatments for depression may need a recalibration, as emerging data suggests their…
Read More
Well-characterized biospecimens assist development of cancer immunotherapies
A landmark immuno-oncology study, spearheaded by scientists at Roche Pharma Research in Basel, Switzerland, has leveraged high-quality biospecimens supplied by…
Read More
What if psilocybin works about as well for depression as an SSRI?
Emerging data from recent studies and meta-analyses suggest that the highly anticipated efficacy of classic psychedelics, particularly psilocybin, in treating…
Read MoreWhat if psilocybin works about as well for depression as an SSRI?
The burgeoning hope surrounding classic psychedelics as a transformative treatment for depression is beginning to confront the sobering realities of…
Read More
What if psilocybin works about as well for depression as an SSRI?
The fervent hope surrounding classic psychedelics as a revolutionary treatment for depression may be tempering, with recent data suggesting that…
Read More
The American Midlife Crisis: Why Middle-Aged Adults in the United States Are Falling Behind Their Global Peers in Health and Well-Being
For decades, the concept of the "midlife crisis" in the United States was synonymous with a sudden desire for a…
Read MoreYOU MAY HAVE MISSED
